Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20121
20142
20152
20161
20172
20191
20201
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting4
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Daiichi Sankyo1
Hamamatsu University1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Japan Adjuvant Study Group of Pancreatic Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms19
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms5
Esophageal Neoplasms4
Melanoma4
Breast Neoplasms3
Head and Neck Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.